Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | selumetinib:decitabine (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.0051 | 0.9 |
mRNA | TPCA-1 | CTRPv2 | pan-cancer | AAC | 0.0047 | 0.9 |
mRNA | BRD-K96970199 | CTRPv2 | pan-cancer | AAC | 0.011 | 0.9 |
mRNA | NSC 74859 | CTRPv2 | pan-cancer | AAC | -0.0054 | 0.9 |
mRNA | JQ-1 | CTRPv2 | pan-cancer | AAC | 0.0044 | 0.9 |
mRNA | BRD-K16147474 | CTRPv2 | pan-cancer | AAC | 0.0055 | 0.9 |
mRNA | bendamustine | CTRPv2 | pan-cancer | AAC | -0.0052 | 0.9 |
mRNA | AZD-2281 | CTRPv2 | pan-cancer | AAC | -0.0044 | 0.9 |
mRNA | Erlotinib | gCSI | pan-cancer | AAC | -0.0078 | 0.9 |
mRNA | BRD-K44224150 | CTRPv2 | pan-cancer | AAC | -0.0099 | 0.9 |